ÂÜÀòÂÒÂ×

Molly Salyers has extensive experience in regulatory affairs, primarily in the pharmaceutical industry. Molly is currently working as the Director, Regulatory Affairs Product Lead - Oncology at Amunix Pharmaceuticals, starting in 2023. Prior to this, they held the position of Director, Regulatory Affairs at Equillium, Inc. from January 2023 to July 2023, and the role of Associate Director Regulatory Affairs from August 2021 to February 2023. Before joining Equillium, Molly worked at Amgen as a Senior Manager in Regulatory Affairs from May 2019 to August 2021, and as a Regulatory Affairs Manager from September 2017 to May 2019. Molly also gained experience at CytRx Corporation, where they held various roles including Regulatory Affairs Manager and Regulatory Affairs Specialist. Molly's career in regulatory affairs started at WIL Research Laboratories, where they worked as a Compliance Specialist and later as a Publishing Specialist.

Molly Salyers completed their Bachelor of Arts degree in English at The Ohio State University from 2000 to 2004.